Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. (Q48468846)
Jump to navigation
Jump to search
scientific article published on 31 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. |
scientific article published on 31 October 2014 |
Statements
1 reference
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. (English)
1 reference
Dan Atar
1 reference
Henry Krum
1 reference
Andrew R Kompa
1 reference
Thomas G von Lueder
1 reference
Bing H Wang
1 reference
Li Huang
1 reference
Randy Webb
1 reference
Pierre Jordaan
1 reference
31 October 2014
1 reference
1 reference
8
1 reference
1
1 reference
71-78
1 reference
Identifiers
1 reference